BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9038273)

  • 1. Endolymphatic stromal myosis associated with tamoxifen use.
    Eddy GL; Mazur MT
    Gynecol Oncol; 1997 Feb; 64(2):262-4. PubMed ID: 9038273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade endometrial stromal sarcoma following tamoxifen treatment.
    Engin H
    Gynecol Oncol; 2008 Jan; 108(1):253-4. PubMed ID: 17928038
    [No Abstract]   [Full Text] [Related]  

  • 3. High-grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer.
    Sesti F; Patrizi L; Ermini B; Palmieri G; Orlandi A; Piccione E
    Gynecol Obstet Invest; 2005; 60(2):117-20. PubMed ID: 15920338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-grade endometrial stromal sarcoma of the ectocervix after therapy for breast cancer.
    Boardman CH; Webb MJ; Jefferies JA
    Gynecol Oncol; 2000 Oct; 79(1):120-3. PubMed ID: 11006043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial stromal sarcoma with sex cord-like differentiation associated with tamoxifen therapy.
    Pang LC
    South Med J; 1998 Jun; 91(6):592-4. PubMed ID: 9634127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine pleomorphic rhabdomyosarcoma in a patient receiving tamoxifen therapy.
    Okada DH; Rowland JB; Petrovic LM
    Gynecol Oncol; 1999 Dec; 75(3):509-13. PubMed ID: 10600318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial cancer after tamoxifen treatment: a descriptive study of 25 breast cancer patients who subsequently developed endometrial cancer.
    Peters-Engl C; Medl M; Danmayr E; Mirau M; Alth G; Leodolter S
    Anticancer Res; 1996; 16(5B):3241-6. PubMed ID: 8920798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor.
    Leiser AL; Hamid AM; Blanchard R
    Gynecol Oncol; 2004 Aug; 94(2):567-71. PubMed ID: 15297205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas.
    Altaras MM; Aviram R; Cohen I; Cordoba M; Yarkoni S; Beyth Y
    Gynecol Oncol; 1993 May; 49(2):255-8. PubMed ID: 8504996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal therapy of endometrial stromal sarcoma.
    Reich O; Regauer S
    Curr Opin Oncol; 2007 Jul; 19(4):347-52. PubMed ID: 17545798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients.
    Robinson DC; Bloss JD; Schiano MA
    Gynecol Oncol; 1995 Nov; 59(2):186-90. PubMed ID: 7590470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iatrogenic endometrial megapolyps in women with breast carcinoma.
    Berezowsky J; Chalvardjian A; Murray D
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):727-30. PubMed ID: 9205466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade endometrial stromal sarcoma developing in a postmenopausal woman under toremifene treatment for breast cancer.
    Kashiyama T; Oda K; Kawana K; Arimoto T; Kanetaka Y; Takazawa Y; Maeda D; Nakagawa S; Yano T; Kozuma S
    J Obstet Gynaecol Res; 2013 Jan; 39(1):424-9. PubMed ID: 22690656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial stromal sarcoma development after hysterectomy and tamoxifen therapy.
    Christie DB; Day JD; Moore AB; Chapman JR; Nakayama DK; Conforti AM
    Am Surg; 2008 Aug; 74(8):726-8. PubMed ID: 18705574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.
    Hubalek M; Ramoni A; Mueller-Holzner E; Marth C
    Gynecol Oncol; 2004 Oct; 95(1):264-6. PubMed ID: 15385144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial stromal sarcoma: objective response to letrozole.
    Maluf FC; Sabbatini P; Schwartz L; Xia J; Aghajanian C
    Gynecol Oncol; 2001 Aug; 82(2):384-8. PubMed ID: 11531300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory endometrial adenocarcinoma in a tamoxifen user with breast cancer after menopause.
    Wu CJ; Peng YJ; Yu MH; Chen CH
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):88-90. PubMed ID: 17389201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.